このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effects of Neuro-Athletic Training on Performance Parameters and Injury Risk in Taekwondo Athletes

2026年7月8日 更新者:Rabia Nur Ata Ozturk、Pamukkale University

Our study is a randomized controlled trial. The aim of the study is to investigate the effects of neuro-athletic training on balance, agility, jump performance parameters, and injury risk in Taekwondo athletes.

Hypotheses H0: Neuro-athletic training has no effects on balance, agility, jump performance parameters, and injury risk in Taekwondo athletes.

H1: Neuro-athletic training has effects on balance, agility, jump performance parameters, and injury risk in Taekwondo athletes.

Sample

A total of 26 participants will be included in the study. Randomization will be used to divide them into two groups:

Experimental group: 13 participants Control group: 13 participants Inclusion Criteria

  • Regular participation in Taekwondo training for at least 2 years
  • No musculoskeletal injury within the last 6 months
  • Participation in Taekwondo training at least 2 days per week during the past 2 years
  • Athletes with an anterior reach distance asymmetry of 4 cm or more after Y-Balance Test (YBT)
  • Voluntary participation in the study Exclusion criteria for participants;
  • Having had hip/pelvis, knee, or ankle surgery in the past year,
  • Having a neurological disease,
  • Using any medication that could affect balance, having a vestibular system disorder,
  • Having a diagnosis of attention deficit.

調査の概要

状態

積極的、募集していない

詳細な説明

Our study is a randomized controlled trial. The aim of the study is to investigate the effects of neuro-athletic training on balance, agility, jump performance parameters, and injury risk in Taekwondo athletes.

The hypotheses are as follows:

H0: Neuro-athletic training has no effects on balance, agility, jump performance parameters, and injury risk in Taekwondo athletes.

H1: Neuro-athletic training has effects on balance, agility, jump performance parameters, and injury risk in Taekwondo athletes.

A total of 26 participants will be included in the study. Randomization will be used to divide them into two groups: 13 participants in the experimental group and 13 participants in the control group.

nclusion criteria for participants are: regular participation in Taekwondo training for at least two years, no musculoskeletal injury within the last six months, participation in Taekwondo training at least two days per week during the past two years, anterior reach distance asymmetry of 4 cm or more after the Y-Balance Test (YBT), and voluntary participation in the study.

Exclusion criteria are: hip/pelvis, knee, or ankle surgery within the last year, presence of a neurological disorder, use of any medication that may affect balance, vestibular system disorders, and diagnosis of attention deficit. Power analysis was conducted using G*Power 3.1 software to determine the sample size. For repeated measures ANOVA with two groups and two measurement points, the effect size reported in a previous study for the Taekwondo-Specific Agility Test (TSAT) variable (η²p = 0.26) was taken as reference. With α = 0.05 and power (1-β) = 0.95, a total of 26 participants was calculated to be sufficient.

Participants, both male and female athletes, will be randomized into two groups using the sealed envelope method. Each group will consist of 13 athletes. In the experimental group, athletes will perform a neuro-athletic exercise program in addition to their regular training program, while athletes in the control group will continue only with their regular training. he study is planned to last eight weeks. Athletes will continue their normal training routines, but those in the experimental group will perform neuro-athletic exercises twice a week during the warm-up phase of their training. The program consists of 15-20 minutes of neuro-athletic exercises, as described in Table 1, and will be implemented for eight weeks. Assessments will be conducted at baseline and at the end of the eighth week (pre-test and post-test).

All participants will be informed in detail about the purpose of the study, procedures, and forms used, and written informed consent will be obtained.

The methods of evaluation include anthropometric measurements, Y-Balance Test, Reactive Balance Test, vertical jump assessment, and the Taekwondo-Specific Agility Test.

The study is planned to be conducted at Konya Selçuklu Municipality Sports School.

The expected benefit of the study is that neuro-athletic training, which focuses on the training of the central and peripheral nervous system, will improve communication between the brain and the body, thereby enhancing movement quality and training quality. For Taekwondo athletes, balance, agility, and jump height are crucial for success in competitions. Although the literature suggests that neuro-athletic training improves these parameters, the number of clinical studies is limited. Therefore, the expected benefit of this study is to clinically demonstrate the effectiveness of neuro-athletic training, enhance athlete performance, and contribute to injury prevention.

研究の種類

介入

入学 (推定)

26

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Inclusion criteria:

  • Attending taekwondo training regularly for at least 2 years
  • Not having had any muscle or skeletal injuries in the last 6 months
  • Training in taekwondo at least 2 days a week in the past 2 years
  • Athletes with anterior reach distance asymmetry of 4 cm or more after YDT
  • Being willing to participate in the study

Exclusion criteria:

  • Having had hip/pelvis, knee, or ankle surgery in the past year
  • Having a neurological disease
  • Using any medication that could affect balance, having a vestibular system disorder
  • Being diagnosed with attention deficit

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:study group
In addition to their regular workouts, the athletes will follow a neuroathletic training program for 8 weeks.
Neuroathletic training is a treatment approach that, in addition to regular training, provides athletes with more sensory input to the central nervous system and trains them neurologically.
It is a regular training program prepared for athletes specific to the sport field.
アクティブコンパレータ:Control group
Athletes in this group will continue their regular training prepared by their sport-specific coaches for 8 weeks.
It is a regular training program prepared for athletes specific to the sport field.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Risk of injury
時間枠:start and 8 weeks
The risk of injury will be assessed with the Y Balance Test. There are no specific upper or lower limits in the Y Balance Test; however, clinically accepted threshold values exist. The most critical threshold is an asymmetry greater than 4 cm between legs in the anterior direction and a composite score of less than 94%, which significantly increases the risk of injury.
start and 8 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Reactive Balance Test
時間枠:start and 8 weeks
The Reactive Balance Test (RBT) assesses an individual's ability to maintain balance when exposed to unexpected external stimuli. It evaluates neuromotor adaptability through measures such as response time, accuracy, and time to stability. While there are no fixed upper or lower limits, clinically meaningful thresholds-like prolonged response times or reduced accuracy-are used to identify impaired performance and increased injury risk. In the Reactive Balance Test, there are no fixed upper or lower limits; instead, clinically meaningful thresholds (e.g., response time >0.6 s, low accuracy) are considered indicators of risk.
start and 8 weeks
Vertical Jump Assessment
時間枠:start and 8 week
The Vertical Jump Assessment (Vertical Jump Test) is a widely used method to measure an athlete's explosive lower-body power by recording how high they can jump vertically. It does not have fixed "upper or lower limits," but jump height values are interpreted against normative data for age, gender, and sport.
start and 8 week
TSAT (Taekwondo-Specific Agility Test)
時間枠:Start and 8 week

TSAT (Taekwondo-Specific Agility Test): It is an agility test that includes rapid changes of direction, sprinting, and kicking combinations specific to taekwondo athletes.

Purpose: To measure sport-specific agility, anaerobic capacity, and movement control.

Application: The athlete performs rapid changes of direction over set distances and executes taekwondo techniques (e.g., roundhouse kick).

There are no fixed upper or lower limits; performance is evaluated based on time and movement accuracy, and normative values are interpreted according to the athlete's level."

Start and 8 week
Athlete Injury Anxiety Scale
時間枠:start and 8 week

SIAS (Sport Injury Anxiety Scale): Developed by Rex & Metzler (2016), it measures the tendency of athletes to perceive injury situations as threatening.

Purpose: To evaluate the psychological impact of injury risk on athletes, including fear of reinjury, loss of performance, and social consequences.

Format: 21 items, 5-point Likert scale (1 = strongly disagree, 5 = strongly agree).

It does not have fixed upper or lower limits; instead, it uses subscales to capture different dimensions of injury-related anxiety.

start and 8 week

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディディレクター:FATMA ÜNVER, PROFESÖR、Pamukkale Üniversitesi

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年10月1日

一次修了 (推定)

2026年9月1日

研究の完了 (推定)

2027年10月1日

試験登録日

最初に提出

2026年6月20日

QC基準を満たした最初の提出物

2026年7月8日

最初の投稿 (実際)

2026年7月14日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月14日

QC基準を満たした最後の更新が送信されました

2026年7月8日

最終確認日

2025年10月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • PamukkaleU-FTR-RA-01

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

Neuro-athletic trainingの臨床試験

3
購読する